Studies have shown that HRD1 interacts with ACLY in non‐alcoholic fatty liver disease, thereby promoting ACLY ubiquitination leading to its degradation.47 The gene discussed is SYVN1; the disease is metabolic dysfunction-associated steatotic liver disease.